
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
Mandy Reece, PharmD, CDCES, BC-ADM, BCACP, FADCES, vice chair and associate professor in the department of pharmacy practice at Philadelphia College of Osteopathic Medicine, discusses diabetes care, change in treatment, and management.
In this week’s episode, we spoke with Mandy Reece, PharmD, CDCES, BC-ADM, BCACP, FADCES, vice chair and associate professor in the department of pharmacy practice at Philadelphia College of Osteopathic Medicine, on diabetes care, change in treatment, and management.





